|
|
Developments in imaging technology and software continue to help cardiac magnetic resonance imaging (MRI) exams gain prominence in the medical imaging market by meeting the demand for faster scan times and the ability to view areas of the body that were previously thought impossible to image, according to a market research report.
According to healthcare market research firm Kalorama Information (New York, NY, USA), this trend will drive sales of MRI equipment. Kalorama projects sales of MRI equipment to customers in the still underutilized cardiac area to grow between 2.5% and 4% beginning in 2010. World market revenue for MRI systems used in heart-cardio scanning is forecast to reach US$605 million in 2012, up from $556 million in 2008.
"While it's likely that an ECG [electrocardiography] and angiography will be utilized before a cardiac MRI, the 3D [three-dimensional] whole heart applications provide an additional option for cardiologists," said Bruce Carlson, publisher of Kalorama Information. "MRI will increasingly be used not just for more complicated applications, such as assessing a cardiac tumor, or evaluating congenital heart disease prior to surgery."
New MRI systems featuring advanced 32-coil designs, low signal-to-noise ratio, and improved image acquisition have driven the new uses. In addition to providing physicians with a noninvasive technique for acquiring comprehensive data related to cardiovascular function and disease, cardiac MRI exams offer rapid analysis and increased accuracy. The modality has also proven useful diagnosing various unusual cardiovascular problems. The speed of MRI systems has earned them a place as an important research tool for studying ischemia and cardiomyopathy. While new techniques can noninvasively image the coronary arteries in a way that is more precise than angiography, Kalorama still expects that they are constrained by the need for staff trained in making cardiac MRI evaluations.
Moreover, cardiac MRI has proven useful in unexpected ways that are helping to promote growth in the market. For instance, it can demonstrate the effects of airway pressure therapy on the hearts of patients with obstructive sleep apnea. This capability could open the modality to a large market in the United States, where about 18 million people have obstructive sleep apnea or similar sleep-related breathing disorders.
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. |
|
发表于 2009-10-12 11:02:37
